Persistent Hyperinsulinemic Hypoglycemia of Infancy: A Rare Case with Multiple Anomalies

Document Type : Case Report


1 Department of Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran

2 Department of Pediatrics, Mashhad University of Medical Sciences, Mashhad, Iran

3 Student Research Committee, Medicine Faculty, Mashhad University of Medical Sciences, Mashhad, Iran

4 Department of Pathology, Mashhad University of Medical Sciences, Mashhad, Iran


Background: Few cases of persistent hyperinsulinemic hypoglycemia of infancy (PHHI) have been reported, so far. The main concern in the management of PHHI is to prevent severe hypoglycemia, which can lead to coma, brain damage and mental retardation. Total or subtotal pancreatectomy is normally required for the infants, despite the availability of medical therapies.
Case report: In this report, we present the case of a three-day-old male infant with hypoglycemia and seizure, admitted to a hospital in Mashhad with the diagnosis of PHHI. Further evaluations revealed multiple congenital disorders including dextrocardia, posterior communicating aneurysm, atrial septal defect, ventricular septal defect, situs inversus and asplenia. Maximal doses of diazoxide, octreotide and intravenous glucose were prescribed for the infant. The patient was referred to our hospital and subtotal pancreatectomy was performed. In addition, due to frequent hypoglycemic episodes, a near-total pancreatectomy was conducted six days after the first surgery. The patient died eight months after total pancreatectomy at the age of nine months with no follow-ups.
Conclusion: Infants with PHHI are at a high risk of severe neurological damage due to severe hypoglycemia, unless immediate and adequate medical interventions are carried out. Considering the co-occurrence of different congenital anomalies and PHHI in the present case, further assessment of concomitant congenital disorders is highly recommended in PHHI patients.


  1. Goel P, Choudhury SR. Persistent hyperinsulinemic hypoglycemia of infancy: An overview of current concepts. J Indian Assoc Pediatr Surg. 2012; 17(3):99-103.
  2. Shilyansky J, Fisher S, Cutz E, Perlman K, Filler RM. Is 95% pancreatectomy the procedure of choice for treatment of persistent hyperinsulinemic hypoglycemia of the neonate? J Pediatr Surg. 1997; 32(2):342-6.
  3. Wahid F, Al Onazi M, Al Rawaf A, Al Muhaidly M, Al Otaibi A, Al Hudhaif J. Persistent hyperinsulinemic hypoglycemia of infancy: long-term follow-up after surgical treatment. Annal Pediatr Surg. 2013; 7(4):123-5.
  4. Harris JP, Ricker AT, Gray RS, Steed RD, Gutal JJ. Reversible hypertrophic cardiomyopathy associated with nesidioblastosis. J Pediatr. 1992; 120(2):272-5.
  5. Rizzo G, Arduini D, Romanini C. Accelerated cardiac growth and abnormal cardiac flow in fetuses of type I diabetic mothers. Obstet Gynecol. 1992; 80(3 Pt 1):369-76.
  6. Massin MM, Van Elmbt G, Soyeur D. Reversible hypertrophic cardiomyopathy in congenital hyperinsulinism. Acta cardiol. 1999; 54(6):359-61.
  7. Bulbul A, Bolat F, Comert S, Demirin H, Tanik C, Bulbul L, et al. Persistent hyperinsulinemic hypoglycemia with left ventricular hypertrophy and dysrhythmia: a case report. Fetal Pediatr Pathol. 2010; 29(3):165-71.
  8. de Lonlay P, Fournet JC, Rahier J, Gross-Morand MS, Poggi-Travert F, Foussier V, et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest. 1997; 100(4):802-7.
  9. Verkarre V, Fournet JC, de Lonlay P, Gross-Morand MS, Devillers M, Rahier J, et al. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest. 1998; 102(7):1286-91.

10. Stanley CA, Lieu YK, Hsu BY, Burlina AB, Greenberg CR, Hopwood NJ, et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med. 1998; 338(19):1352-7.

11. Thornton PS, MacMullen C, Ganguly A, Ruchelli E, Steinkrauss L, Crane A, et al. Clinical and molecular characterization of a dominant form of congenital hyperinsulinism caused by a mutation in the high-affinity sulfonylurea receptor. Diabetes. 2003; 52(9):2403-10.

12. Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med. 1998; 338(4):226-30.

13. Aynsley-Green A, Dune MJ, James RF, Lindley KJ. Ions and genes in persistent hyperinsulinemic hypoglycemia in infancy: A commentary on the implications for tailoring treatment to disease pathogenesis. J Pediatr Endocrinol Metab. 1998; 11(Suppl 1):121-9.

14. Sawathiparnich P, Likitmaskul S, Angsusingha K, Nimkarn S, Chaichanwatanakul K, Laohapansang M, et al. Persistent hyperinsulinemic hypoglycemia of infancy: experience at Siriraj Hospital. J Med Assoc Thai. 2002; 85(Suppl 2):S506-12.

15. Palladino AA, Stanley CA. A specialized team approach to diagnosis and medical versus surgical treatment of infants with congenital hyperinsulinism. Semin Pediatr Surg. 2011; 20(1):32-7.

16. Yasukura K, Ono A, Woo M, Matsuzaki S, Iwase S, Kobayashi Y. A mild case of nesidioblastosis with diagnostic and therapeutic difficulty. Pediatr Int. 1993; 35(3):258-61.

Semiz S, Bircan I, Akçurin S, Mihci E, Melikoglu M, Karaguzel G, et al. Persistent hyperinsulinaemic hypoglycaemia of infancy: case report. East Afr Med J. 2002; 79(10):554-6.